Lethal effects of mitochondria via microfluidics.

Area of Science:

• Cell Biology
• Cancer Research
• Mitochondrial Dynamics

Background:

• Tumor cells exhibit morphologic changes in response to therapy, including the formation of tunneling nanotubes.
• Mitochondria play crucial roles in cellular processes, including apoptosis and intercellular communication.

Purpose of the Study:

• To investigate the role of mitochondria in tunneling nanotube formation and intercellular transfer between breast tumor cells.
• To explore the potential of mitochondria as therapeutic agents for inducing tumor cell death.

Main Methods:

• Utilized a tomographic microscope to visualize intracellular structures and mitochondrial migration.
• Employed a microfluidic device to mimic tunneling nanotubes and study mitochondrial transfer and cargo release.
• Assessed the apoptotic effects of transferred mitochondria and endonuclease G (Endo G) in tumor cells.
• Investigated the synergistic effects of transferred mitochondria with doxorubicin.

Main Results:

• Mitochondria were observed migrating through tunneling nanotubes from one breast tumor cell to another.
• Transferred mitochondria released endonuclease G (Endo G) into recipient tumor cells, termed 'unsealed mitochondria'.
• Unsealed mitochondria induced apoptosis in tumor cells, particularly in response to caspase-3 activation.
• Endonuclease G-depleted mitochondria failed to induce significant cell death, highlighting Endo G's critical role.
• Unsealed mitochondria demonstrated synergistic apoptotic effects when combined with doxorubicin, enhancing tumor cell death.

Conclusions:

• Mitochondrial transfer via tunneling nanotubes is a mechanism for intercellular communication in breast tumor cells.
• The release of endonuclease G from transferred mitochondria can trigger apoptosis in recipient tumor cells.
• Targeting mitochondrial transfer and endonuclease G release presents a novel therapeutic strategy for cancer treatment, potentially enhanced by combination therapies like doxorubicin.